Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
Perico N, Remuzzi G, Griffin MD, Cockwell P, Maxwell AP, Casiraghi F, Rubis N, Peracchi T, Villa A, Todeschini M, Carrara F, Magee BA, Ruggenenti PL, Rota S, Cappelletti L, McInerney V, Griffin TP, Islam MN, Introna M, Pedrini O, Golay J, Finnerty AA, Smythe J, Fibbe WE, Elliman SJ, O'Brien T; NEPHSTROM Trial Consortium. Perico N, et al. Among authors: mcinerney v. J Am Soc Nephrol. 2023 Oct 1;34(10):1733-1751. doi: 10.1681/ASN.0000000000000189. Epub 2023 Aug 10. J Am Soc Nephrol. 2023. PMID: 37560967 Clinical Trial.
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalities.
Mohamed SA, Howard L, McInerney V, Hayat A, Krawczyk J, Naughton S, Finnerty A, Holohan M, Duffy A, Moloney T, Kavanagh E, Burke P, Liew A, Tubassam M, Walsh SR, O'Brien T. Mohamed SA, et al. Among authors: mcinerney v. Cytotherapy. 2020 Jun;22(6):313-321. doi: 10.1016/j.jcyt.2020.02.007. Epub 2020 Apr 6. Cytotherapy. 2020. PMID: 32273232 Free article. Clinical Trial.
GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor.
Fitzgerald JC, Duffy N, Cattaruzzi G, Vitrani F, Paulitti A, Mazzarol F, Mauro P, Sfiligoj A, Curcio F, Jones DM, McInerney V, Krawczyk J, Kelly J, Finnerty A, McDonagh K, McCabe U, Duggan M, Connolly L, Shaw G, Murphy M, Barry F. Fitzgerald JC, et al. Among authors: mcinerney v. Front Bioeng Biotechnol. 2022 Mar 9;10:834267. doi: 10.3389/fbioe.2022.834267. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35356775 Free PMC article.
Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with "no-option" critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial.
Mohamed SA, Duffy A, McInerney V, Krawczyk J, Hayat A, Naughton S, Finnerty A, Holohan M, Liew A, Tubassam M, Walsh SR, O'Brien T, Howard L. Mohamed SA, et al. Among authors: mcinerney v. Cytotherapy. 2022 Dec;24(12):1259-1267. doi: 10.1016/j.jcyt.2022.07.002. Epub 2022 Aug 20. Cytotherapy. 2022. PMID: 35999133 Free article.
Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.638C > T; p.Arg213Gln (NUIGi063-A, NUIGi063-B, NUIGi063-C) and 3 healthy controls (NUIGi064-A, NUIGi064-B, NUIGi064-C).
Stewart R, Gadoud C, Krawczyk J, McInerney V, O'Brien T, Shen S, Allen NM. Stewart R, et al. Among authors: mcinerney v. Stem Cell Res. 2023 Jun;69:103093. doi: 10.1016/j.scr.2023.103093. Epub 2023 Apr 11. Stem Cell Res. 2023. PMID: 37071954 Free article.
Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.881C > T; p.Ala294Val (NUIGi059-A, NUIGi059-B, NUIGi059-C) and 3 healthy controls (NUIGi060-A, NUIGi060-B, NUIGi060-C).
Stewart R, Gadoud C, Krawczyk J, McInerney V, O'Brien T, Shen S, Allen NM. Stewart R, et al. Among authors: mcinerney v. Stem Cell Res. 2023 Sep;71:103191. doi: 10.1016/j.scr.2023.103191. Epub 2023 Aug 25. Stem Cell Res. 2023. PMID: 37659345 Free article.
Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
Ge N, Liu M, Krawczyk J, McInerney V, Galvin J, Shen S, O'Brien T, Prendiville T. Ge N, et al. Among authors: mcinerney v. Stem Cell Res. 2019 Aug;39:101502. doi: 10.1016/j.scr.2019.101502. Epub 2019 Jul 26. Stem Cell Res. 2019. PMID: 31415974 Free article.
90 results